FDA Grants Full Approval to Game-Changing Drug for Alzheimer Disease | Docwire News
The FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval.
Related Articles
NIH: Topical Steroid Withdrawal Identified as Separate Condition From Eczema | Docwire News
Individuals with TSW had elevated levels of a form of vitamin B3, causing inflammation separate from eczema symptoms.
Annual US Measles Cases Top 1,000, Worst Year Since Elimination | Docwire News
There have been 12 outbreaks in 2025 so far, defined as three or more related cases.
Severe Obesity Rates Surge in U.S. and Driven by Rise in BMI | Docwire News
Researchers report a sharp increase in extreme forms of obesity in the U.S.
RFK Jr.’s Vaccine Policies Spark Alarm Among Public Health Experts | Docwire News
The NoiseFilter team expresses deep concern over policy changes to vaccine strategy following RFK Jr’s appointment.
New Insight Into Stability of Two Skin Microbiome Species | Docwire News
The researchers focused on microbial changes that occur from childhood to adulthood and stability of existing microbiomes.
Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research | Docwire News
Parkinson’s disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease | Docwire News
The primary safety endpoint of minimal SAEs was met as well as the secondary endpoint of increased fluorodopa in the putamen.
Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors | Docwire News
This provides rationale for the clinical evaluation of defactinib and avutometinib in the treatment of melanoma metastases.
The Role of Multidisciplinary Care in Head and Neck Cancer | Docwire News
Dr. Eric Dr. Bergson about the importance of head and neck cancer awareness, how to integrate screening into routine care.
Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection | Docwire News
The universal coronavirus vaccine targets the low-mutation stalk region of the virus.